Andera Partners — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Cyllene Therapeuticscyllene-tx.comJul 2026
Cyllene Therapeutics develops a gene therapy platform based on non-replicative Herpes Simplex Virus 1 (nrHSV-1) vectors to deliver DNA medicines for patients with severe localized chronic diseases.
BiotechDeep TechDigital Health
Co-investorsM VenturesBpifrance
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.